BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 32430337)

  • 21. Epigenome-wide methylation in DNA from peripheral blood as a marker of risk for breast cancer.
    Severi G; Southey MC; English DR; Jung CH; Lonie A; McLean C; Tsimiklis H; Hopper JL; Giles GG; Baglietto L
    Breast Cancer Res Treat; 2014 Dec; 148(3):665-73. PubMed ID: 25407397
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical significance of promoter methylation status of tumor suppressor genes in circulating DNA of pancreatic cancer patients.
    Singh N; Rashid S; Rashid S; Dash NR; Gupta S; Saraya A
    J Cancer Res Clin Oncol; 2020 Apr; 146(4):897-907. PubMed ID: 32146565
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Genome-wide DNA methylation analysis of KRAS mutant cell lines.
    Tew BY; Durand JK; Bryant KL; Hayes TK; Peng S; Tran NL; Gooden GC; Buckley DN; Der CJ; Baldwin AS; Salhia B
    Sci Rep; 2020 Jun; 10(1):10149. PubMed ID: 32576853
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Methylation markers of early-stage non-small cell lung cancer.
    Lokk K; Vooder T; Kolde R; Välk K; Võsa U; Roosipuu R; Milani L; Fischer K; Koltsina M; Urgard E; Annilo T; Metspalu A; Tõnisson N
    PLoS One; 2012; 7(6):e39813. PubMed ID: 22768131
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Novel methylation biomarker panel for the early detection of pancreatic cancer.
    Yi JM; Guzzetta AA; Bailey VJ; Downing SR; Van Neste L; Chiappinelli KB; Keeley BP; Stark A; Herrera A; Wolfgang C; Pappou EP; Iacobuzio-Donahue CA; Goggins MG; Herman JG; Wang TH; Baylin SB; Ahuja N
    Clin Cancer Res; 2013 Dec; 19(23):6544-6555. PubMed ID: 24088737
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Whole blood DNA aberrant methylation in pancreatic adenocarcinoma shows association with the course of the disease: a pilot study.
    Dauksa A; Gulbinas A; Barauskas G; Pundzius J; Oldenburg J; El-Maarri O
    PLoS One; 2012; 7(5):e37509. PubMed ID: 22629410
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Integrative genomic analysis identifies epigenetic marks that mediate genetic risk for epithelial ovarian cancer.
    Koestler DC; Chalise P; Cicek MS; Cunningham JM; Armasu S; Larson MC; Chien J; Block M; Kalli KR; Sellers TA; Fridley BL; Goode EL
    BMC Med Genomics; 2014 Jan; 7():8. PubMed ID: 24479488
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Methylation of the SPARC gene promoter and its clinical implication in pancreatic cancer.
    Gao J; Song J; Huang H; Li Z; Du Y; Cao J; Li M; Lv S; Lin H; Gong Y
    J Exp Clin Cancer Res; 2010 Mar; 29(1):28. PubMed ID: 20338068
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Differential methylation landscape of pancreatic ductal adenocarcinoma and its precancerous lesions.
    Bararia A; Dey S; Gulati S; Ghatak S; Ghosh S; Banerjee S; Sikdar N
    Hepatobiliary Pancreat Dis Int; 2020 Jun; 19(3):205-217. PubMed ID: 32312637
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Genome-wide DNA methylation profiling shows a distinct epigenetic signature associated with lung macrophages in cystic fibrosis.
    Chen Y; Armstrong DA; Salas LA; Hazlett HF; Nymon AB; Dessaint JA; Aridgides DS; Mellinger DL; Liu X; Christensen BC; Ashare A
    Clin Epigenetics; 2018 Dec; 10(1):152. PubMed ID: 30526669
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Genome-wide DNA methylation profiles altered by Helicobacter pylori in gastric mucosa and blood leukocyte DNA.
    Zhang Y; Zhang XR; Park JL; Kim JH; Zhang L; Ma JL; Liu WD; Deng DJ; You WC; Kim YS; Pan KF
    Oncotarget; 2016 Jun; 7(24):37132-37144. PubMed ID: 27206798
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The application of methylation specific electrophoresis (MSE) to DNA methylation analysis of the 5' CpG island of mucin in cancer cells.
    Yokoyama S; Kitamoto S; Yamada N; Houjou I; Sugai T; Nakamura S; Arisaka Y; Takaori K; Higashi M; Yonezawa S
    BMC Cancer; 2012 Feb; 12():67. PubMed ID: 22329852
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Methylome-Wide Association Study in Peripheral White Blood Cells Focusing on Central Obesity and Inflammation.
    Arpón A; Milagro FI; Ramos-Lopez O; Mansego ML; Riezu-Boj JI; Martínez JA;
    Genes (Basel); 2019 Jun; 10(6):. PubMed ID: 31212707
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Genome-wide DNA methylation differences according to oestrogen receptor beta status in colorectal cancer.
    Neumeyer S; Popanda O; Edelmann D; Butterbach K; Toth C; Roth W; Bläker H; Jiang R; Herpel E; Jäkel C; Schmezer P; Jansen L; Alwers E; Benner A; Burwinkel B; Hoffmeister M; Brenner H; Chang-Claude J
    Epigenetics; 2019 May; 14(5):477-493. PubMed ID: 30931802
    [TBL] [Abstract][Full Text] [Related]  

  • 35. DNA methylation array analysis identifies profiles of blood-derived DNA methylation associated with bladder cancer.
    Marsit CJ; Koestler DC; Christensen BC; Karagas MR; Houseman EA; Kelsey KT
    J Clin Oncol; 2011 Mar; 29(9):1133-9. PubMed ID: 21343564
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparative DNA methylomic analyses reveal potential origins of novel epigenetic biomarkers of insulin resistance in monocytes from virally suppressed HIV-infected adults.
    Dye CK; Corley MJ; Li D; Khadka VS; Mitchell BI; Sultana R; Lum-Jones A; Shikuma CM; Ndhlovu LC; Maunakea AK
    Clin Epigenetics; 2019 Jun; 11(1):95. PubMed ID: 31253200
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Discovery of Molecular DNA Methylation-Based Biomarkers through Genome-Wide Analysis of Response Patterns to BCG for Bladder Cancer.
    Ilijazi D; Pulverer W; Ertl IE; Lemberger U; Kimura S; Abufaraj M; D'Andrea D; Pradere B; Bruchbacher A; Graf A; Soria F; Susani M; Haitel A; Molinaro L; Pycha A; Comploj E; Pabinger S; Weinhäusel A; Egger G; Shariat SF; Hassler MR
    Cells; 2020 Aug; 9(8):. PubMed ID: 32764425
    [TBL] [Abstract][Full Text] [Related]  

  • 38. An analysis about heterogeneity among cancers based on the DNA methylation patterns.
    Liu Y; Gu Y; Su M; Liu H; Zhang S; Zhang Y
    BMC Cancer; 2019 Dec; 19(1):1259. PubMed ID: 31888612
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Methylation of immune-regulatory cytokine genes and pancreatic cancer outcomes.
    Huang BZ; Binder AM; Sugar CA; Chao CR; Setiawan VW; Zhang ZF
    Epigenomics; 2020 Aug; 12(15):1273-1285. PubMed ID: 32867538
    [No Abstract]   [Full Text] [Related]  

  • 40. Clinicopathological Significance of CDKN2A Promoter Hypermethylation Frequency with Pancreatic Cancer.
    Tang B; Li Y; Qi G; Yuan S; Wang Z; Yu S; Li B; He S
    Sci Rep; 2015 Sep; 5():13563. PubMed ID: 26338139
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.